Highlights
NASDAQ: KMPH       Kempharm Inc
Last Price Today's Change   Day's Range   Trading Volume
5.98   -0.14 (2.29%)  5.98 - 6.09  94,977

Overview

 
Avg Volume (4 weeks):2,311,180
4 Weeks Range:5.07 - 6.27
4 Weeks Price Volatility (%):
75.83%
52 Weeks Range:0.18 - 6.27
52 Weeks Price Volatility (%):
95.24%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

KemPharm Inc is a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs that believe will be improved versions of widely prescribed, approved drugs. The company uses its Ligand Activated Therapy (LAT) platform technology to create prodrugs. Its LAT platform technology discovers and develops prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability, and safety. KemPharm's two lead product candidates are KP415, ER d-threo-methylphenidate product candidate for the treatment of ADHD, and KP201/IR, APAP-free, single-entity, benzhydrocodone hydrochloride IR abuse-deterrent product candidate designed for the treatment of acute pain.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2204  3859  563  3253 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNDL 0.74+0.05 
 LK 1.38+1.38 
 WPX 9.43+0.48 
 BNGO 8.54+1.59 
 AVGR 1.56+0.45 
 BB 10.965+1.855 
 HTZ 0.00-1.75 
 GPOR 0.1380.00 
 CTRM 0.341-0.019 
 OBSV 3.66+1.14 

TOP ARTICLES

1. Daily Futures Trading Strategy 15 January 2021 Where Futures Lies
2. Equities Retreated on Waning Optimism State of The Markets
3. CryptoNews of the Week CryptoNews
4. Markets Mixed on Hedging State of The Markets
5. Impeachment, Stimulus And The Markets Wall Street Breakfast